Marty has over 20 years of industry experience and a proven track record of developing successful CDMO market entry strategies and building global brands.Before joining Mabion, he was Vice President of Biologics at Pharmaron, expanding the company's C> and biologics manufacturing portfolio into North America. Previously, he held CDMO leadership positions at Hospira (now Pfizer One2One), Therapure (now part of Resilience) and August Bioservices. Earlier in his career, Marty held leadership roles at large life science companies including Boehringer Ingelheim, Oscient Pharmaceuticals and Specialty Labs. Marty holds an MBA in Finance and Management from the University of Notre Dame, a certificate in pharmaceutical and biologics leadership from the Wharton School at the University of Pennsylvania and a bachelor's degree in Marketing from DePaul University.
